Organizing Committee
OCM Member
Deakin University , Australia
Biography :

Professor Jagat R Kanwar is the Head and team leader of Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Faculty of Health, Deakin University, Australia. Professor Kanwar has an international reputation and expertise in investigating fundamental and applied molecular signalling aspects of pathogenesis of cancer, chronic inflammation and neurodegenerative diseases, thereby, leading to the development of treatment strategies from bench to bedside. He has more than 150 research publications in high impact factor and peer reviewed international journals, 27 book chapters and 3 edited books. Prof Kanwar’s research has generated several patents/PCTs with more than five licensed patents for commercialization to BioPharma industry. His group is currently working on drug discovery and nanomedicine for oral and systemic drug delivery of a range of natural bioactive and biomacromolecules (proteins/peptides, siRNAs and aptamers) for targeting survivin, HIF-1? and other apoptotic and inflammatory cell signalling molecules in cancer, chronic inflammation and neurodegenerative disorders. His research combines Immunology with state of the art and cutting edge techniques in Molecular Biology, Biochemistry, Nanobiotechnology and visualization to investigate the pathways in which key molecules are regulated in both normal and disease states. A number of in vitro human cell/tissue based co-culture models for cancers, microbial infections; autoimmune diseases; chronic inflammatory diseases (osteoarthritis, inflammatory bowel disease), gut health, neurodegeneration and immunomodulation have been developed by his group. Kanwar’s main research objective is to understand and target the mechanisms involved at the molecular and sub cellular level which gives us an edge over the prevalent targeting techniques. He carries out both academic and commercial research projects and develops new approaches for the diagnosis, treatment, and nanomedicine based new generation delivery systems. His recent research focus on locked nucleic acid (LNA) LNA-modified aptamers conjugated "double targeted nano-bullet nanocapsules" with natural anti-tumour proteins which specifically target cancer cells.

OCM Member
Goodwin Research Laboratory , USA
Biography :

Dr. Masoud H Manjili is an Assistant Professor of Immunology at the Department of Microbiology Immunology Virginia Commonwealth University School of Medicine and Member of Massey Cancer Center Richmond VA. He conducted his postdoctoral fellowship at Roswell Park Cancer Institute Buffalo NY 1999-2003. He has received a PhD in Immunology from The University of Sydney Australia 1993-1996. He has received a DVM from The University of Tehran Iran 1983-1990. He is serving as a Managing Editor of Frontiers in Bioscience. Research Interest: Tumor Immunology Tumor Immunoediting Cancer Vaccines Adoptive T cell Therapy Myeloid-derived suppressor cells (MDCS) Cancer Stem Cells Graft-versus-host disease (GVHD) Breast Cancer Neuroblastoma

Research Interest :

Research Interest: Tumor Immunology Tumor Immunoediting Cancer Vaccines Adoptive T cell Therapy Myeloid-derived suppressor cells (MDCS) Cancer Stem Cells Graft-versus-host disease (GVHD) Breast Cancer Neuroblastoma

OCM Member
Boston University , USA
Biography :

Guanglan Zhang is an Assistant Professor and the faculty coordinator of the Health Informatics Program at Computer Science Department, Metropolitan College (MET) at Boston University. She leads the research activities at MET health informatics research lab. She is also an adjunct member of Bioinformatics Core at Cancer Vaccine Center (CVC), Dana-Farber Cancer Institute (DFCI) and Harvard Medical School. During the many years of pursuing research in biomedical and health sciences, Guanglan has authored more than 50 publications and developed more than a dozen online computational systems. Through the development of advanced computational solutions, she contributes to the rapid progress of basic and applied biology and biomedicine.

OCM Member
Emory University School of Medicine , USA
Biography :

Dr. Max Cooper, MD is an allergist/immunologist in Atlanta, Georgia. He is currently licensed to practice medicine in Alabama. He is a Professor at Emory University School of Medicine. His laboratory pursues ontogenetic and phylogenetic studies of the adaptive immune system in parallel with the analysis of immunological diseases in humans. Current projects include the role of immunoglobulin and non-immunoglobulin genes in B cell development, and the evolution of adaptive immune systems in vertebrates.

Research Interest :

His laboratory pursues ontogenetic and phylogenetic studies of the adaptive immune system in parallel with the analysis of immunological diseases in humans. Current projects include the role of immunoglobulin and non-immunoglobulin genes in B cell development, and the evolution of adaptive immune systems in vertebrates.

OCM Member
Ben Gurion University of Negev , Israel
Biography :

Noah Isakov - Short Biography Professor Noah Isakov holds the Joseph H Krupp Chair in Cancer Immunobiology at the Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, at Ben Gurion University of the Negev, in Beer Sheva, Israel. He graduated from the Weizmann Institute of Science in Rehovot, Israel (1981) and worked as a postdoctoral researcher at the University of Minnesota in Minneapolis, MN (1981-1983) and the Scripps Research Institute in La Jolla, CA (1983-1987). He performed sabbaticals at the NICHD, National Institutes of Health in Bethesda, MD (1993-1995), the Oklahoma Medical Research Foundation in Oklahoma City, OK, where he held the Esther Greenberg Honors Chair in Biomedical Research (2003-2004), and the Otago University in Dunedin, New Zealand (2015).

OCM Member
Al-Qadisya University , Iraq
Biography :

Hammady Al Hilali studied B.Sc in 1987, M.Sc. in 1996, from Baghdad University College of Science, Iraq and pursued Ph.D. in 2006 in Immunology. He has more than thirteen published papers and supervising more than thirteen Master’s and Ph.D. students in Medical Microbiology. He is Member of department of Medical Microbiology, College of Medicine, Al-Qadisiya University. His Research focuses on the immunology of major auto-immune disease, IBD.

Research Interest :

Research interest in diagnostic immunology and in individual variation regarding single nucleotide polymorphisms of many immunological factors during the courses of different auto-immune diseases, e.g., type 1 and 2 Diabetes mellitus, Celiac disease, inflammatory bowel disease, Acne vulgaris, and Asthma are among other disease were the subject of more than 25 published researches. Attendee and speaker at 6 international conferences in the field of immunology, a scientific committee member in one of them, more than 15 national conferences as well. Many international workshops, fellowships, and training courses (Iowa state university, USA/ Mahidol university, Thailand, are examples). Member of editorial board in journal of clinical and cellular immunology (USA), and member of many related associations. Consultant at Ad-diwaniah teaching hospital, immunology and virology diagnostic lab.

OCM Member
Federal University of Rio de Janeiro , Brazil
Biography :

He is the principal investigator at the Laboratoty of Immunobiology at Federal University of Rio de Janeiro, Associate Professor at Federal University of Rio de Janeiro, and a Senior Research Specialist from the Presidency of the Oswaldo Cruz Foundation-FIOCRUZ where he investigate the immunological mechanisms associated with changes in central and peripheral lymphoid system in infectious diseases, with major focus in Malaria, Leishmaniasis and Chagas Diseases.

Research Interest :

Research Specialist from the Presidency of the Oswaldo Cruz Foundation-FIOCRUZ

OCM Member
Bawa Biotech LLC , USA
Biography :

Raj Bawa is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm based in Ashburn, VA, USA that he founded in 2002. He is an inventor, entrepreneur, professor and registered patent agent licensed to practice before the U.S. Patent & Trademark Office. Trained as a biochemist and microbiologist, he has been an active researcher for over two decades. He has extensive expertise in pharmaceutical sciences, biotechnology, nanomedicine, drug delivery and biodefense, FDA regulatory issues, and patent law. Since 1999, he has held various positions at Rensselaer Polytechnic Institute in Troy, NY, where he is currently an adjunct professor of biological sciences and where he received his doctoral degree in three years (biophysics/biochemistry). Since 2004, he has been an adjunct professor of natural and applied sciences at NVCC in Annandale, VA. He is a scientific advisor to Teva Pharmaceutical Industries, Ltd., Israel. He has served as a principal investigator of National Cancer Institute SBIRs and reviewer for both the NIH and NSF. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner for 6 years. He is a life member of Sigma Xi, co-chair of the Nanotech Committee of the American Bar Association and serves on the global advisory council of the World Future Society. He is frequently interviewed by the media and appeared in such publications as Nature, MIT Technology Review, American Chemical Socitye CE&N, Business Review, etc. He has authored over 100 publications, co-edited four texts and serves on the editorial boards of 17 peer-reviewed journals, including serving as a Special Associate Editor of Nanomedicine (Elsevier) and an Editor-in-Chief of the Journal of Interdisciplinary Nanomedicine (Wiley). Some of Dr. Bawa’s awards include the Innovations Prize from the Institution of Mechanical Engineers, London, UK (2008); Appreciation Award from the Undersecretary of Commerce, Washington, DC (2001); the Key Award from Rensselaer’s Office of Alumni Relations (2005); and Lifetime Achievement Award from the American Society for Nanomedicine (2014).

Research Interest :

Since 2002, Dr. Bawa is listed on the official “Roster of Attorneys and Agents” maintained by the US Patent & Trademark Office (PTO) as a registered patent agent in good standing, licensed to practice before the PTO.

OCM Member
University of North Texas Health Science Center at Fort Worth , USA
Biography :

Dr. Su's research has received international recognition in understanding molecular regulation of T-cell immune system aging, focusing on the thymic microenvironment, and associated with aging-induced immune-senescence, autoimmune predisposition, and age-related chronic inflammatory diseases. His team has published more than 40 peer reviewed papers, made significant contributions to defining how aged microenvironment (thymic epithelium) affects hematopoietic stem cell regeneration competence. Currently, his team is clarifying the clinical significance about a balance of self-reactive and regulatory T cells, generated in the aged involuted thymus, which profoundly involve age-related chronic inflammatory condition; and his team is also ascertaining a novel role of the central T-cell immune system on tumor chemotherapy.

Mail us at

Program enquiry
immunologycongress@alliedconferences.org
Sponsors / Exhibiting / Advertising
annualimmunology@alliedconferences.org
General Queries
immunologycongress@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

Insurance

Registration fees do not include insurance of any kind.

Transportation

Please note that any (or) all transportation and parking is the responsibility of the registrant.

Press/Media

Press permission must be obtained from Allied academies Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied academies are a non-profit organization. This conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact immunologycongress@alliedconferences.org to request a personalized letter of invitation.

 

Regarding refunds, all bank charges will be for the registrants account.

 

Cancellation, Postponement and Transfer of Registration

All cancellations or modifications of registration must be made in writing to immunologycongress@alliedconferences.org

Cancellation Policy

If Allied academies cancel this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied academies conferences event which must occur within one year from the date of cancellation.

Postponement

If Allied academies postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another Allied academies conferences event which must occur within one year from the date of postponement.

Transfer of registration

All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to immunologycongress@alliedconferences.org. Details must be included with the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:

Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.

 

 

Copyright © 2017-2018 Allied Academies, All Rights Reserved.